Home » Tenders » Americas » USA » Interventional Agents Safety and Pharmacokinetic Services Tender, USA - 96701204

Interventional Agents Safety and Pharmacokinetic Services Tender, USA - 96701204

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Interventional Agents Safety and Pharmacokinetic Services. The project location is USA and the tender is closing on 22 Feb 2024. The tender notice number is 75N93024R00003, while the TOT Ref Number is 96701204. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Interventional Agents Safety and Pharmacokinetic Services

Deadline : 22 Feb 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 96701204

Document Ref. No. : 75N93024R00003

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

The aim of the upcoming solicitation is to create a multiple award Indefinite Delivery/Indefinite Quantity (IDIQ) type contract.

The development and introduction of new therapeutic products against potential agents of bioterrorism, drug-resistant pathogens, emerging and re-emerging infectious diseases, as well as infectious diseases prevalent in resource-limited countries remains a high public health priority. To assist in filling these public health gaps, the NIAID requires a nontraditional, proactive, and product development-oriented program to provide preclinical and non-clinical development support for promising therapeutic candidates that emerge from academia, the private sector, or other sources. The suite of services will encompass those activities commonly associated with the development of interventional products for infectious disease required for New Drug Applications (NDA), Biologic License Applications (BLA), and/or Investigational New Drug (IND) applications.

For the purposes of this contract, an Interventional Agent is a chemical or biological agent for control of diseases caused by pathogens or toxins. The provided services shall be directed at the following:

Diseases caused by pathogens and toxins on the National Institute of Allergy and Infectious Diseases (NIAID) Emerging Infectious Diseases/Pathogens list (https://www.niaid.nih.gov/research/emerging-infectious-diseases-pathogens) Emerging and re-emerging infectious diseases Antimicrobial-resistant and multi-drug-resistant infections Bacterial infections Fungal infections Viral infections Parasitic diseasesNIAID anticipates awarding multiple Indefinite Delivery, Indefinite Quantity (IDIQ) contracts to organizations that demonstrate capability to fulfill the technical requirements of at least one (1) of the technical Task Areas listed below plus required Task Area F. A contract may be awarded to an organization proposing to fulfill any number or combination of the tech...
Active Contract Opportunity Notice ID 75N93024R00003 Related Notice 75N93024R00003 Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Feb 08, 2024 10:57 am EST
Original Response Date: Feb 22, 2024 03:00 pm EST
Inactive Policy: Manual
Original Inactive Date: Jun 30, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: AN11 - Health R&D Services; Health care services; Basic Research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance: